drugset / Trial / NCT00737048

A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain

NCT00737048

Phase 3 Completed 328 enrolled Janssen Pharmaceutical K.K.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of JNS013 with single oral dose administration in participants with pain after tooth-extraction of mandibular impacted wisdom tooth.

Timeline

Start
2008-03
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral
Subject Tramadol Other / unclassified 75 mg Oral

Indications

No indication recorded.